XML 46 R35.htm IDEA: XBRL DOCUMENT v3.21.2
EQUITY (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Subsidiary, Sale of Stock [Line Items]          
Common stock, shares issued 39,687,589   39,687,589   39,687,589
Common stock, shares outstanding 39,687,589   39,687,589    
Common stock par value $ 0.01   $ 0.01   $ 0.01
Number of options granted during period     165,000    
Fair value of options granted during period     $ 62,000    
Number of options exercised        
Intrinsic value of options outstanding $ 177,000   $ 177,000   $ 29,000
Intrinsic value of options exercisable 134,000   134,000    
Compensation cost, non-vested awards not yet recognized 73,000   73,000    
Selling, General and Administrative Expenses [Member]          
Subsidiary, Sale of Stock [Line Items]          
Stock based compensation expense $ 21,000 $ 13,000 $ 36,000 $ 19,000  
Non Employee Stock Option [Member]          
Subsidiary, Sale of Stock [Line Items]          
Number of options exercised 0   0    
Companys CFO [Member]          
Subsidiary, Sale of Stock [Line Items]          
Number of options granted during period 100,000   100,000    
Directors [Member]          
Subsidiary, Sale of Stock [Line Items]          
Number of options granted during period     30,000    
Companys CEO [Member]          
Subsidiary, Sale of Stock [Line Items]          
Number of options granted during period     35,000    
Non Employee [Member]          
Subsidiary, Sale of Stock [Line Items]          
Number of options granted during period 0   0    
Amended And Restated Two Thousand Six Stockincentive Plan [Member]          
Subsidiary, Sale of Stock [Line Items]          
Number of options available for grant 1,576,394   1,576,394